These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 1849041)

  • 1. Mechanisms involved in the evolution of progestin resistance in human breast cancer cells.
    Murphy LC; Dotzlaw H; Wong MS; Miller T; Murphy LJ
    Cancer Res; 1991 Apr; 51(8):2051-7. PubMed ID: 1849041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor gene expression in human endometrial adenocarcinoma cells: regulation by progestins.
    Gong Y; Anzai Y; Murphy LC; Ballejo G; Holinka CF; Gurpide E; Murphy LJ
    Cancer Res; 1991 Oct; 51(20):5476-81. PubMed ID: 1833051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
    Reddel RR; Alexander IE; Koga M; Shine J; Sutherland RL
    Cancer Res; 1988 Aug; 48(15):4340-7. PubMed ID: 3390830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells.
    Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL
    Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor receptor signaling enhanced by long-term medroxyprogesterone acetate treatment in endometrial carcinoma.
    Zhao S; Chen X; Lu X; Yu Y; Feng Y
    Gynecol Oncol; 2007 Apr; 105(1):45-54. PubMed ID: 17240435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.
    Murphy LJ; Sutherland RL; Stead B; Murphy LC; Lazarus L
    Cancer Res; 1986 Feb; 46(2):728-34. PubMed ID: 3000583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor: receptor and ligand expression in human breast cancer.
    Murphy LC; Dotzlaw H; Wong MS; Miller T; Mrockowski B; Gong Y; Murphy LJ
    Semin Cancer Biol; 1990 Oct; 1(5):305-15. PubMed ID: 2103505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
    Koga M; Musgrove EA; Sutherland RL
    Cancer Res; 1989 Jan; 49(1):112-6. PubMed ID: 2642286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models.
    Pennanen PT; Sarvilinna NS; Purmonen SR; Ylikomi TJ
    Steroids; 2009; 74(4-5):404-9. PubMed ID: 19146866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor gene expression in human breast cancer cells: regulation of expression by progestins.
    Murphy LC; Murphy LJ; Dubik D; Bell GI; Shiu RP
    Cancer Res; 1988 Aug; 48(16):4555-60. PubMed ID: 3260816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous growth factor expression in T-47D, human breast cancer cells, associated with reduced sensitivity to antiproliferative effects of progestins and antiestrogens.
    Murphy LC; Dotzlaw H
    Cancer Res; 1989 Feb; 49(3):599-604. PubMed ID: 2783382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphological and biochemical features of a medroxyprogesterone acetate (MPA)-resistant MCF-7 breast cancer cell line.
    Gibelli N; Zibera C; Sica G; Carbone M; Pedrazzoli P; Robustelli della Cuna G
    Anticancer Res; 1994; 14(1A):37-43. PubMed ID: 7909420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of retinoic acid receptors in human breast cancer cells.
    Roman SD; Clarke CL; Hall RE; Alexander IE; Sutherland RL
    Cancer Res; 1992 Apr; 52(8):2236-42. PubMed ID: 1313739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of estrogen receptors in estrogen receptor-negative human breast carcinoma cells: modulation of epidermal growth factor-receptor (EGF-R) and transforming growth factor alpha (TGF alpha) gene expression.
    Sheikh MS; Shao ZM; Chen JC; Li XS; Hussain A; Fontana JA
    J Cell Biochem; 1994 Mar; 54(3):289-98. PubMed ID: 8200909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.
    Horwitz KB; Freidenberg GR
    Cancer Res; 1985 Jan; 45(1):167-73. PubMed ID: 3838085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered gene expression in drug-resistant human breast cancer cells.
    Wosikowski K; Schuurhuis D; Kops GJ; Saceda M; Bates SE
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2405-14. PubMed ID: 9815641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.